Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan

NCT01805232 is registered in ClinicalTrials.gov with University of Khartoum as lead sponsor.

NCT NCT01805232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01805232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan
Lead sponsor
University of Khartoum
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2013
Completion date
July 31, 2013
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria